Skip to content

Clinical trials

Enrolling by invitation Stomach Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Status: Enrolling by invitation Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20233
20241
20258
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Qilu Hospital of Shandong University3
Affiliated Hospital of Jiangnan University2
Affiliated Hospital of Nantong University1
Dong Peng1
Fujian Medical University1
Liu Yang1
Nanjing Medical University1
Qun Zhao1
Tianjin Medical University Cancer Institute and Hospital1
Wenzhou Central Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms14
Breast Neoplasms2
Carcinoma, Transitional Cell2
Frailty1
Lymphatic Metastasis1
Metabolic Syndrome1
Postoperative Complications1
Recurrence1
Sleep Apnea, Obstructive1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.